substance p has been researched along with Postoperative Nausea and Vomiting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, D; Lu, M; Shen, W; Wang, L; Wang, Y; Wu, A; Xiong, C; Yue, Y | 1 |
| Black, LS; D'Angelo, R; Dalby, PL; Gesztesi, Z; MacLean, D; Scuderi, PE; Wender, RH; White, PF; Wright, W | 1 |
1 trial(s) available for substance p and Postoperative Nausea and Vomiting
| Article | Year |
|---|---|
Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures.
Topics: Administration, Oral; Adult; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hysterectomy; Injections, Intravenous; Neurokinin-1 Receptor Antagonists; Ondansetron; Piperidines; Placebos; Postoperative Nausea and Vomiting; Preanesthetic Medication; Risk Factors; Serotonin Antagonists; Substance P | 2000 |
1 other study(ies) available for substance p and Postoperative Nausea and Vomiting
| Article | Year |
|---|---|
Perioperative use of centrally acting angiotensin-converting enzyme inhibitor may increase patients' risk for postoperative nausea and vomiting.
Topics: Angiotensin-Converting Enzyme Inhibitors; Brain; Central Nervous System Agents; Evidence-Based Medicine; Humans; Incidence; Models, Biological; Perioperative Care; Postoperative Nausea and Vomiting; Risk Factors; Substance P | 2016 |